Association Between Expression of Immune Response-Related Genes and Response to Nivolumab in Metastatic Non-Small Cell Lung Cancer

被引：0
|
作者：
Obuti Saito, A. [1 ]
Araujo, D. [2 ]
Sousa Filho, C. [1 ]
Sa, D. [1 ]
Walter, L. [3 ]
Silva, A. P. [3 ]
Berra, C. [4 ]
Germano, J. [5 ]
Pinto, C. [6 ]
Carraro, D. M. [4 ]
De Lima, V. C. [1 ]
机构：
[1] AC Camargo Canc Ctr, Med Oncol, Sao Paulo, Brazil
[2] Hosp Base, Sao Jose Do Rio Preto, Brazil
[3] AC Camargo Canc Ctr, Biobank, Sao Paulo, Brazil
[4] AC Camargo Canc Ctr, Int Res Ctr, Genom & Mol Biol Grp, Sao Paulo, Brazil
[5] AC Camargo Canc Ctr, Stat, Sao Paulo, Brazil
[6] AC Camargo Canc Ctr, Pathol, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Nivolumab; gene expression profile; non-small-cell lung carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P33.19
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [31] Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer
    Tokaca, Nadza
    Wotherspoon, Andrew
    Nicholson, Andrew G.
    Fotiadis, Nicos
    Thompson, Lisa
    Popat, Sanjay
    LUNG CANCER, 2017, 111 : 65 - 68
  • [32] A Retrospective Analysis of Nivolumab-Related Pneumonitis in Non-Small Cell Lung Cancer Patients
    Tsujino, S.
    Ikeda, T.
    Taniguchi, H.
    Shimada, M.
    Gyoutoku, H.
    Senju, H.
    Yamaguchi, H.
    Nakatomi, K.
    Fukuda, M.
    Mukae, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2432 - S2432
  • [33] Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness
    Cortijo-Cascajares, Susana
    Cristina Cercos-Lleti, Ana
    Ortiz-Perez, Sara
    Manuel Caro-Teller, Jose
    Miguel Ferrari-Piquero, Jose
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, : 290 - 298
  • [34] Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
    Kim, Hee Kyung
    Heo, Mi Hwa
    Lee, Han Sang
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 591 - 598
  • [35] Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
    Federico Carbone
    Francesco Grossi
    Aldo Bonaventura
    Alessandra Vecchié
    Silvia Minetti
    Nicholas Bardi
    Edoardo Elia
    Anna Maria Ansaldo
    Daniele Ferrara
    Erika Rijavec
    Maria Giovanna Dal Bello
    Federica Biello
    Giovanni Rossi
    Marco Tagliamento
    Angela Alama
    Simona Coco
    Paolo Spallarossa
    Franco Dallegri
    Carlo Genova
    Fabrizio Montecucco
    Clinical & Experimental Metastasis, 2019, 36 : 449 - 456
  • [36] Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
    Carbone, Federico
    Grossi, Francesco
    Bonaventura, Aldo
    Vecchie, Alessandra
    Minetti, Silvia
    Bardi, Nicholas
    Elia, Edoardo
    Ansaldo, Anna Maria
    Ferrara, Daniele
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Biello, Federica
    Rossi, Giovanni
    Tagliamento, Marco
    Alama, Angela
    Coco, Simona
    Spallarossa, Paolo
    Dallegri, Franco
    Genova, Carlo
    Montecucco, Fabrizio
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (05) : 449 - 456
  • [37] A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
    Ito, Keima
    Oguri, Tetsuya
    Takeda, Norihisa
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Tajiri, Tomoko
    Ohkubo, Hirotsugu
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Niimi, Akio
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 29
  • [38] Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer
    Yasuda, Yuichiro
    Urata, Yoshiko
    Tohnai, Rie
    Ito, Shoichi
    Kawa, Yoshitaka
    Kono, Yuko
    Hattori, Yoshihiro
    Tsuda, Masahiro
    Sakuma, Toshiko
    Negoro, Shunichi
    Satouchi, Miyako
    INTERNAL MEDICINE, 2018, 57 (09) : 1269 - 1272
  • [39] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [40] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
12345